The early correction of complete atrioventricular septal defect before the onset of irreversible pulmonary hypertension is currently a routine approach. In the last two decades, improvements in surgical techniques and postoperative approaches have significantly decreased the in-hospital mortality caused by this disease. Despite these developments, long-term outcomes and reoperation rates remain problematic. This article reviews factors affecting recurrent left atrioventricular valve dysfunction and reoperations and their management options.